Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy

Association of Grave's ophthalmopathy with hyperthyroidism is well known, and it has also been reported in euthyroid or hypothyroid autoimmune thyroiditis, which rarely requires treatment. Here, we report a case of bilaterally symmetrical severe corticosteroid-resistant hypothyroid Grave's ophthalmopathy successfully treated with rituximab.

[1]  Maria K. Stilling‐Vinther,et al.  Fatal Pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis , 2012, Acta ophthalmologica.

[2]  F. Pakdel,et al.  Hyperthyroid vs hypothyroid eye disease: the same severity and activity , 2011, Eye.

[3]  Bobby S. Korn,et al.  Rituximab for thyroid eye disease. , 2011, Ophthalmology.

[4]  L. Min,et al.  Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. , 2011, European journal of endocrinology.

[5]  F. Angrilli,et al.  The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis , 2011, Leukemia & lymphoma.

[6]  Terry J. Smith,et al.  Targeted biological therapies for Graves’ disease and thyroid‐associated ophthalmopathy. Focus on B‐cell depletion with Rituximab , 2011, Clinical endocrinology.

[7]  A. Tripathi,et al.  The Role of Intravenous Methylprednisolone Immunosuppression in the Management of Active Thyroid Eye Disease , 2010, Orbit.

[8]  J. Wall,et al.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role? , 2010, Clinical ophthalmology.

[9]  T. Njo,et al.  Four patients with hypothyroid Graves' disease. , 2010, The Netherlands journal of medicine.

[10]  A. Bhattacharyya,et al.  Thiazolidinedione precipitated thyroid associated ophthalmopathy. , 2010, The Journal of the Association of Physicians of India.

[11]  J. Wall,et al.  Eye and eyelid abnormalities are common in patients with Hashimoto's thyroiditis. , 2010, Thyroid : official journal of the American Thyroid Association.

[12]  Terry J. Smith,et al.  Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. , 2010, Ophthalmology.

[13]  E. Kirsch,et al.  Graves' orbitopathy: current imaging procedures. , 2009, Swiss medical weekly.

[14]  N. Morgenthaler,et al.  Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy , 2009, British Journal of Ophthalmology.

[15]  K. Kumar,et al.  Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease , 2009, Postgraduate Medical Journal.

[16]  Terry J. Smith,et al.  B Cells from Patients with Graves’ Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis1 , 2008, The Journal of Immunology.

[17]  C. Vogel,et al.  Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. , 2008, Rheumatology.

[18]  D. Szydlarska,et al.  Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report. , 2008, Polskie Archiwum Medycyny Wewnetrznej.

[19]  M. Nardi,et al.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. , 2008, European journal of endocrinology.

[20]  L. Hegedüs,et al.  B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  M. Žarković,et al.  Hypothyroid Graves ophthalmopathy: a case report , 2007 .

[22]  D. Dazzi,et al.  Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. , 2007, European journal of endocrinology.

[23]  H. Holte,et al.  Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. , 2007, Haematologica.

[24]  L. Hegedüs,et al.  Quality of life in patients with benign thyroid disorders. A review. , 2006, European journal of endocrinology.

[25]  G. Silverman,et al.  Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. , 2003, Arthritis and rheumatism.

[26]  E. Mezosi,et al.  Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. , 2000, European journal of endocrinology.

[27]  L. Wartofsky,et al.  Graves' ophthalmopathy: current concepts regarding pathogenesis and management. , 1993, Endocrine reviews.

[28]  S. Kurose,et al.  Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report. , 1992, Endocrinologia japonica.